Literature DB >> 2229561

Proton MR spectroscopy and imaging of the brain in AIDS: evidence of neuronal loss in regions that appear normal with imaging.

D K Menon1, C J Baudouin, D Tomlinson, C Hoyle.   

Abstract

Central nervous system involvement is increasingly being recognised as a common manifestation of the acquired immunodeficiency syndrome (AIDS), either as a direct effect of the human immunodeficiency virus, or as a result of secondary infection or malignancy. A subset of patients with clinical or psychometric evidence of CNS involvement have normal appearances on imaging. This report describes proton magnetic resonance spectroscopy (1H MRS) in two patients with AIDS and discusses the role of 1H MRS in providing a marker of neuronal loss in patients with normal or borderline imaging.

Entities:  

Mesh:

Year:  1990        PMID: 2229561     DOI: 10.1097/00004728-199011000-00003

Source DB:  PubMed          Journal:  J Comput Assist Tomogr        ISSN: 0363-8715            Impact factor:   1.826


  16 in total

Review 1.  Human immunodeficiency virus-associated dementia: an evolving disease.

Authors:  Justin C McArthur; Norman Haughey; Suzanne Gartner; Kathy Conant; Carlos Pardo; Avi Nath; Ned Sacktor
Journal:  J Neurovirol       Date:  2003-04       Impact factor: 2.643

2.  Biochemical changes in the frontal lobe of HIV-infected individuals detected by magnetic resonance spectroscopy.

Authors:  D López-Villegas; R E Lenkinski; I Frank
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-02       Impact factor: 11.205

3.  Proton magnetic resonance spectroscopy of the anterior cingulate gyrus, insular cortex and thalamus in schizophrenia associated with idiopathic unconjugated hyperbilirubinemia (Gilbert's syndrome).

Authors:  Rei Yasukawa; Tsuyoshi Miyaoka; Shoichi Mizuno; Takuji Inagaki; Jun Horiguchi; Kazushige Oda; Hajime Kitagaki
Journal:  J Psychiatry Neurosci       Date:  2005-11       Impact factor: 6.186

4.  Proton MRS and quantitative MRI assessment of the short term neurological response to antiretroviral therapy in AIDS.

Authors:  I D Wilkinson; S Lunn; K A Miszkiel; R F Miller; M N Paley; I Williams; R J Chinn; M A Hall-Craggs; S P Newman; B E Kendall; M J Harrison
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-10       Impact factor: 10.154

5.  Indirect effects of elevated body mass index on memory performance through altered cerebral metabolite concentrations.

Authors:  Mitzi M Gonzales; Takashi Tarumi; Danielle E Eagan; Hirofumi Tanaka; Miral Vaghasia; Andreana P Haley
Journal:  Psychosom Med       Date:  2012-07-20       Impact factor: 4.312

6.  Localised 1H-MR spectroscopy for metabolic characterisation of diffuse and focal brain lesions in patients infected with HIV.

Authors:  I L Simone; F Federico; C Tortorella; C F Andreula; G B Zimatore; P Giannini; G Angarano; V Lucivero; P Picciola; D Carrara; A Bellacosa; P Livrea
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-04       Impact factor: 10.154

Review 7.  Neuropsychiatric aspects of HIV infection.

Authors:  I P Everall
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-04       Impact factor: 10.154

8.  Pathological findings correlated with MRI in HIV infection.

Authors:  C P Hawkins; J E McLaughlin; B E Kendall; W I McDonald
Journal:  Neuroradiology       Date:  1993       Impact factor: 2.804

9.  Neuronal-Glia Markers by Magnetic Resonance Spectroscopy in HIV Before and After Combination Antiretroviral Therapy.

Authors:  Napapon Sailasuta; Jintanat Ananworanich; Sukalaya Lerdlum; Pasiri Sithinamsuwan; James L K Fletcher; Somporn Tipsuk; Mantana Pothisri; Tanate Jadwattanakul; Supunnee Jirajariyavej; Thep Chalermchai; Stephanie Catella; Edgar Busovaca; Akash Desai; Robert Paul; Victor Valcour
Journal:  J Acquir Immune Defic Syndr       Date:  2016-01-01       Impact factor: 3.731

10.  Metabolic alterations in Parkinson's disease after thalamotomy, as revealed by 1H MR spectroscopy.

Authors:  Hyun-Man Baik; Bo-Young Choe; Hyoung-Koo Lee; Tae-Suk Suh; Byung-Chul Son; Jae-Mun Lee
Journal:  Korean J Radiol       Date:  2002 Jul-Sep       Impact factor: 3.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.